FDA approves new drug that could aid MS diagnoses for clinical trials

FDA approves new drug that could aid MS diagnoses for clinical trials

FDA approves new drug that could aid MS diagnoses for clinical trials

A new drug that could make it easier for doctors to diagnose multiple sclerosis in its earlier stages has been approved for its first human trials by the U.S. Food and Drug Administration.